Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

PILAR FONT UGALDEALEJANDRO ESCUDERO CONTRERASALEJANDRO ESCUDERO CONTRERASEDUARDO COLLANTES ESTÉVEZRAFAELA ORTEGA CASTROCARLOS PÉREZ SÁNCHEZ2026-01-292026-01-29201710.1016/j.trsl.2016.12.0032-s2.0-85008329963https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27760Biochemistry (medical)Physiology (medical)Public Health, Environmental and Occupational HealthTocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammationresearch article